APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Drug and Dietary Supplement

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global OTC Drug and Dietary Supplement Market Analysis and Forecast 2026-2032

1 January 2026195 pages

Choose your research edition.

Industry ResearchOTC Drug and Dietary Supplement Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Drug and Dietary Supplement Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal OTC Drug and Dietary Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Drug and Dietary Supplement Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Drug and Dietary Supplement Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global OTC Drug and Dietary Supplement market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for OTC Drug and Dietary Supplement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for OTC Drug and Dietary Supplement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for OTC Drug and Dietary Supplement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for OTC Drug and Dietary Supplement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of OTC Drug and Dietary Supplement include Abbott, Pfizer, GSK, Bayer, Suntory, Reckitt Benckiser, Herbalife, Glanbia and Blackmores, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for OTC Drug and Dietary Supplement, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of OTC Drug and Dietary Supplement, also provides the revenue of main regions and countries. Of the upcoming market potential for OTC Drug and Dietary Supplement, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the OTC Drug and Dietary Supplement revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global OTC Drug and Dietary Supplement market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for OTC Drug and Dietary Supplement revenue, projected growth trends, production technology, application and end-user industry.

OTC Drug and Dietary Supplement Segment by Company

Abbott

Pfizer

GSK

Bayer

Suntory

Reckitt Benckiser

Herbalife

Glanbia

Blackmores

Amway

OTC Drug and Dietary Supplement Segment by Type

Powders

Capsules

Tablets

Liquids

OTC Drug and Dietary Supplement Segment by Application

Convenience Stores

Supermarkets

Pharmacies

OTC Drug and Dietary Supplement Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Drug and Dietary Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Drug and Dietary Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Drug and Dietary Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of OTC Drug and Dietary Supplement in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of OTC Drug and Dietary Supplement company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Drug and Dietary Supplement revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global OTC Drug and Dietary Supplement Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Powders Major Player Table 3. Capsules Major Player Table 4. Tablets Major Player Table 5. Liquids Major Player Table 6. Global OTC Drug and Dietary Supplement Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Convenience Stores Major Player Table 8. Supermarkets Major Player Table 9. Pharmacies Major Player Table 10. OTC Drug and Dietary Supplement Industry Trends Table 11. OTC Drug and Dietary Supplement Industry Drivers Table 12. OTC Drug and Dietary Supplement Industry Opportunities and Challenges Table 13. OTC Drug and Dietary Supplement Industry Restraints Table 14. Global OTC Drug and Dietary Supplement Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global OTC Drug and Dietary Supplement Market Size by Region (2021-2026) & (US$ Million) Table 16. Global OTC Drug and Dietary Supplement Market Share by Region (2021-2026) Table 17. Global OTC Drug and Dietary Supplement Market Size by Region (2027-2032) & (US$ Million) Table 18. Global OTC Drug and Dietary Supplement Market Share by Region (2027-2032) Table 19. Global OTC Drug and Dietary Supplement Revenue by Players (US$ Million) & (2021-2026) Table 20. Global OTC Drug and Dietary Supplement Revenue Market Share by Players (2021-2026) Table 21. Global OTC Drug and Dietary Supplement Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global OTC Drug and Dietary Supplement Key Players Headquarters & Area Served Table 23. Global OTC Drug and Dietary Supplement Players, Product Type & Application Table 24. Global OTC Drug and Dietary Supplement Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global OTC Drug and Dietary Supplement by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global OTC Drug and Dietary Supplement Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global OTC Drug and Dietary Supplement Revenue by Type (2021-2026) & (US$ Million) Table 29. Global OTC Drug and Dietary Supplement Revenue by Type (2027-2032) & (US$ Million) Table 30. Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2021-2026) Table 31. Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2027-2032) Table 32. Global OTC Drug and Dietary Supplement Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global OTC Drug and Dietary Supplement Revenue by Application (2021-2026) & (US$ Million) Table 34. Global OTC Drug and Dietary Supplement Revenue by Application (2027-2032) & (US$ Million) Table 35. Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2021-2026) Table 36. Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2027-2032) Table 37. Abbott Company Information Table 38. Abbott Business Overview Table 39. Abbott OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Abbott OTC Drug and Dietary Supplement Product Portfolio Table 41. Abbott Recent Development Table 42. Pfizer Company Information Table 43. Pfizer Business Overview Table 44. Pfizer OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Pfizer OTC Drug and Dietary Supplement Product Portfolio Table 46. Pfizer Recent Development Table 47. GSK Company Information Table 48. GSK Business Overview Table 49. GSK OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. GSK OTC Drug and Dietary Supplement Product Portfolio Table 51. GSK Recent Development Table 52. Bayer Company Information Table 53. Bayer Business Overview Table 54. Bayer OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Bayer OTC Drug and Dietary Supplement Product Portfolio Table 56. Bayer Recent Development Table 57. Suntory Company Information Table 58. Suntory Business Overview Table 59. Suntory OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Suntory OTC Drug and Dietary Supplement Product Portfolio Table 61. Suntory Recent Development Table 62. Reckitt Benckiser Company Information Table 63. Reckitt Benckiser Business Overview Table 64. Reckitt Benckiser OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Reckitt Benckiser OTC Drug and Dietary Supplement Product Portfolio Table 66. Reckitt Benckiser Recent Development Table 67. Herbalife Company Information Table 68. Herbalife Business Overview Table 69. Herbalife OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Herbalife OTC Drug and Dietary Supplement Product Portfolio Table 71. Herbalife Recent Development Table 72. Glanbia Company Information Table 73. Glanbia Business Overview Table 74. Glanbia OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Glanbia OTC Drug and Dietary Supplement Product Portfolio Table 76. Glanbia Recent Development Table 77. Blackmores Company Information Table 78. Blackmores Business Overview Table 79. Blackmores OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Blackmores OTC Drug and Dietary Supplement Product Portfolio Table 81. Blackmores Recent Development Table 82. Amway Company Information Table 83. Amway Business Overview Table 84. Amway OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Amway OTC Drug and Dietary Supplement Product Portfolio Table 86. Amway Recent Development Table 87. North America OTC Drug and Dietary Supplement Revenue by Type (2021-2026) & (US$ Million) Table 88. North America OTC Drug and Dietary Supplement Revenue by Type (2027-2032) & (US$ Million) Table 89. North America OTC Drug and Dietary Supplement Revenue by Application (2021-2026) & (US$ Million) Table 90. North America OTC Drug and Dietary Supplement Revenue by Application (2027-2032) & (US$ Million) Table 91. North America OTC Drug and Dietary Supplement Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America OTC Drug and Dietary Supplement Revenue by Country (2021-2026) & (US$ Million) Table 93. North America OTC Drug and Dietary Supplement Revenue by Country (US$ Million) & (2027-2032) Table 94. Europe OTC Drug and Dietary Supplement Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe OTC Drug and Dietary Supplement Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe OTC Drug and Dietary Supplement Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe OTC Drug and Dietary Supplement Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe OTC Drug and Dietary Supplement Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe OTC Drug and Dietary Supplement Revenue by Country (2021-2026) & (US$ Million) Table 100. Europe OTC Drug and Dietary Supplement Revenue by Country (US$ Million) & (2027-2032) Table 101. China OTC Drug and Dietary Supplement Revenue by Type (2021-2026) & (US$ Million) Table 102. China OTC Drug and Dietary Supplement Revenue by Type (2027-2032) & (US$ Million) Table 103. China OTC Drug and Dietary Supplement Revenue by Application (2021-2026) & (US$ Million) Table 104. China OTC Drug and Dietary Supplement Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia OTC Drug and Dietary Supplement Revenue by Type (2021-2026) & (US$ Million) Table 106. Asia OTC Drug and Dietary Supplement Revenue by Type (2027-2032) & (US$ Million) Table 107. Asia OTC Drug and Dietary Supplement Revenue by Application (2021-2026) & (US$ Million) Table 108. Asia OTC Drug and Dietary Supplement Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia OTC Drug and Dietary Supplement Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia OTC Drug and Dietary Supplement Revenue by Region (US$ Million) & (2021-2026) Table 111. Asia OTC Drug and Dietary Supplement Revenue by Region (US$ Million) & (2027-2032) Table 112. SAMEA OTC Drug and Dietary Supplement Revenue by Type (2021-2026) & (US$ Million) Table 113. SAMEA OTC Drug and Dietary Supplement Revenue by Type (2027-2032) & (US$ Million) Table 114. SAMEA OTC Drug and Dietary Supplement Revenue by Application (2021-2026) & (US$ Million) Table 115. SAMEA OTC Drug and Dietary Supplement Revenue by Application (2027-2032) & (US$ Million) Table 116. SAMEA OTC Drug and Dietary Supplement Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. SAMEA OTC Drug and Dietary Supplement Revenue by Country (2021-2026) & (US$ Million) Table 118. SAMEA OTC Drug and Dietary Supplement Revenue by Country (US$ Million) & (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. OTC Drug and Dietary Supplement Image Figure 2. Global OTC Drug and Dietary Supplement Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Drug and Dietary Supplement Market Size Share 2021 VS 2025 VS 2032 Figure 4. Powders Image Figure 5. Capsules Image Figure 6. Tablets Image Figure 7. Liquids Image Figure 8. Global OTC Drug and Dietary Supplement Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global OTC Drug and Dietary Supplement Market Size Share 2021 VS 2025 VS 2032 Figure 10. Convenience Stores Image Figure 11. Supermarkets Image Figure 12. Pharmacies Image Figure 13. Global OTC Drug and Dietary Supplement Market Size (US$ Million) & (2021-2032) Figure 14. Global OTC Drug and Dietary Supplement Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global OTC Drug and Dietary Supplement Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global OTC Drug and Dietary Supplement Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global OTC Drug and Dietary Supplement Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global OTC Drug and Dietary Supplement Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2021-2032) Figure 21. Global OTC Drug and Dietary Supplement Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2021-2032) Figure 24. North America OTC Drug and Dietary Supplement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America OTC Drug and Dietary Supplement Revenue Share by Type (2021-2032) Figure 26. North America OTC Drug and Dietary Supplement Revenue Share by Application (2021-2032) Figure 27. North America OTC Drug and Dietary Supplement Revenue Share by Country (2021-2032) Figure 28. United States OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe OTC Drug and Dietary Supplement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe OTC Drug and Dietary Supplement Revenue Share by Type (2021-2032) Figure 33. Europe OTC Drug and Dietary Supplement Revenue Share by Application (2021-2032) Figure 34. Europe OTC Drug and Dietary Supplement Revenue Share by Country (2021-2032) Figure 35. Germany OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China OTC Drug and Dietary Supplement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China OTC Drug and Dietary Supplement Revenue Share by Type (2021-2032) Figure 45. China OTC Drug and Dietary Supplement Revenue Share by Application (2021-2032) Figure 46. Asia OTC Drug and Dietary Supplement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia OTC Drug and Dietary Supplement Revenue Share by Type (2021-2032) Figure 48. Asia OTC Drug and Dietary Supplement Revenue Share by Application (2021-2032) Figure 49. Asia OTC Drug and Dietary Supplement Revenue Share by Region (2021-2032) Figure 50. Japan OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA OTC Drug and Dietary Supplement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA OTC Drug and Dietary Supplement Revenue Share by Type (2021-2032) Figure 58. SAMEA OTC Drug and Dietary Supplement Revenue Share by Application (2021-2032) Figure 59. SAMEA OTC Drug and Dietary Supplement Revenue Share by Country (2021-2032) Figure 60. Brazil OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt OTC Drug and Dietary Supplement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Powders
  • Capsules
  • Tablets
  • Liquids
Applications
  • Convenience Stores
  • Supermarkets
  • Pharmacies
Companies covered
  • Abbott
  • Pfizer
  • GSK
  • Bayer
  • Suntory
  • Reckitt Benckiser
  • Herbalife
  • Glanbia
  • Blackmores
  • Amway

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 OTC Drug and Dietary Supplement Market by Type
  3. 1.2.1 Global OTC Drug and Dietary Supplement Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Powders
  5. 1.2.3 Capsules
  6. 1.2.4 Tablets
  7. 1.2.5 Liquids
  8. 1.3 OTC Drug and Dietary Supplement Market by Application
  9. 1.3.1 Global OTC Drug and Dietary Supplement Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Convenience Stores
  11. 1.3.3 Supermarkets
  12. 1.3.4 Pharmacies
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 OTC Drug and Dietary Supplement Market Dynamics
  1. 2.1 OTC Drug and Dietary Supplement Industry Trends
  2. 2.2 OTC Drug and Dietary Supplement Industry Drivers
  3. 2.3 OTC Drug and Dietary Supplement Industry Opportunities and Challenges
  4. 2.4 OTC Drug and Dietary Supplement Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global OTC Drug and Dietary Supplement Market Perspective (2021-2032)
  2. 3.2 Global OTC Drug and Dietary Supplement Growth Trends by Region
  3. 3.2.1 Global OTC Drug and Dietary Supplement Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global OTC Drug and Dietary Supplement Market Size by Region (2021-2026)
  5. 3.2.3 Global OTC Drug and Dietary Supplement Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global OTC Drug and Dietary Supplement Revenue by Players
  2. 4.1.1 Global OTC Drug and Dietary Supplement Revenue by Players (2021-2026)
  3. 4.1.2 Global OTC Drug and Dietary Supplement Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global OTC Drug and Dietary Supplement Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global OTC Drug and Dietary Supplement Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global OTC Drug and Dietary Supplement Key Players Headquarters & Area Served
  7. 4.4 Global OTC Drug and Dietary Supplement Players, Product Type & Application
  8. 4.5 Global OTC Drug and Dietary Supplement Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global OTC Drug and Dietary Supplement Market CR5 and HHI
  11. 4.6.3 2025 OTC Drug and Dietary Supplement Tier 1, Tier 2, and Tier 3
5 OTC Drug and Dietary Supplement Market Size by Type
  1. 5.1 Global OTC Drug and Dietary Supplement Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global OTC Drug and Dietary Supplement Revenue by Type (2021-2032)
  3. 5.3 Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2021-2032)
6 OTC Drug and Dietary Supplement Market Size by Application
  1. 6.1 Global OTC Drug and Dietary Supplement Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global OTC Drug and Dietary Supplement Revenue by Application (2021-2032)
  3. 6.3 Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott OTC Drug and Dietary Supplement Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer OTC Drug and Dietary Supplement Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 GSK
  14. 7.3.1 GSK Company Information
  15. 7.3.2 GSK Business Overview
  16. 7.3.3 GSK OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GSK OTC Drug and Dietary Supplement Product Portfolio
  18. 7.3.5 GSK Recent Developments
  19. 7.4 Bayer
  20. 7.4.1 Bayer Company Information
  21. 7.4.2 Bayer Business Overview
  22. 7.4.3 Bayer OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bayer OTC Drug and Dietary Supplement Product Portfolio
  24. 7.4.5 Bayer Recent Developments
  25. 7.5 Suntory
  26. 7.5.1 Suntory Company Information
  27. 7.5.2 Suntory Business Overview
  28. 7.5.3 Suntory OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Suntory OTC Drug and Dietary Supplement Product Portfolio
  30. 7.5.5 Suntory Recent Developments
  31. 7.6 Reckitt Benckiser
  32. 7.6.1 Reckitt Benckiser Company Information
  33. 7.6.2 Reckitt Benckiser Business Overview
  34. 7.6.3 Reckitt Benckiser OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Reckitt Benckiser OTC Drug and Dietary Supplement Product Portfolio
  36. 7.6.5 Reckitt Benckiser Recent Developments
  37. 7.7 Herbalife
  38. 7.7.1 Herbalife Company Information
  39. 7.7.2 Herbalife Business Overview
  40. 7.7.3 Herbalife OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Herbalife OTC Drug and Dietary Supplement Product Portfolio
  42. 7.7.5 Herbalife Recent Developments
  43. 7.8 Glanbia
  44. 7.8.1 Glanbia Company Information
  45. 7.8.2 Glanbia Business Overview
  46. 7.8.3 Glanbia OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Glanbia OTC Drug and Dietary Supplement Product Portfolio
  48. 7.8.5 Glanbia Recent Developments
  49. 7.9 Blackmores
  50. 7.9.1 Blackmores Company Information
  51. 7.9.2 Blackmores Business Overview
  52. 7.9.3 Blackmores OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Blackmores OTC Drug and Dietary Supplement Product Portfolio
  54. 7.9.5 Blackmores Recent Developments
  55. 7.10 Amway
  56. 7.10.1 Amway Company Information
  57. 7.10.2 Amway Business Overview
  58. 7.10.3 Amway OTC Drug and Dietary Supplement Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Amway OTC Drug and Dietary Supplement Product Portfolio
  60. 7.10.5 Amway Recent Developments
8 North America
  1. 8.1 North America OTC Drug and Dietary Supplement Revenue (2021-2032)
  2. 8.2 North America OTC Drug and Dietary Supplement Revenue by Type (2021-2032)
  3. 8.2.1 North America OTC Drug and Dietary Supplement Revenue by Type (2021-2026)
  4. 8.2.2 North America OTC Drug and Dietary Supplement Revenue by Type (2027-2032)
  5. 8.3 North America OTC Drug and Dietary Supplement Revenue Share by Type (2021-2032)
  6. 8.4 North America OTC Drug and Dietary Supplement Revenue by Application (2021-2032)
  7. 8.4.1 North America OTC Drug and Dietary Supplement Revenue by Application (2021-2026)
  8. 8.4.2 North America OTC Drug and Dietary Supplement Revenue by Application (2027-2032)
  9. 8.5 North America OTC Drug and Dietary Supplement Revenue Share by Application (2021-2032)
  10. 8.6 North America OTC Drug and Dietary Supplement Revenue by Country
  11. 8.6.1 North America OTC Drug and Dietary Supplement Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America OTC Drug and Dietary Supplement Revenue by Country (2021-2026)
  13. 8.6.3 North America OTC Drug and Dietary Supplement Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe OTC Drug and Dietary Supplement Revenue (2021-2032)
  2. 9.2 Europe OTC Drug and Dietary Supplement Revenue by Type (2021-2032)
  3. 9.2.1 Europe OTC Drug and Dietary Supplement Revenue by Type (2021-2026)
  4. 9.2.2 Europe OTC Drug and Dietary Supplement Revenue by Type (2027-2032)
  5. 9.3 Europe OTC Drug and Dietary Supplement Revenue Share by Type (2021-2032)
  6. 9.4 Europe OTC Drug and Dietary Supplement Revenue by Application (2021-2032)
  7. 9.4.1 Europe OTC Drug and Dietary Supplement Revenue by Application (2021-2026)
  8. 9.4.2 Europe OTC Drug and Dietary Supplement Revenue by Application (2027-2032)
  9. 9.5 Europe OTC Drug and Dietary Supplement Revenue Share by Application (2021-2032)
  10. 9.6 Europe OTC Drug and Dietary Supplement Revenue by Country
  11. 9.6.1 Europe OTC Drug and Dietary Supplement Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe OTC Drug and Dietary Supplement Revenue by Country (2021-2026)
  13. 9.6.3 Europe OTC Drug and Dietary Supplement Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China OTC Drug and Dietary Supplement Revenue (2021-2032)
  2. 10.2 China OTC Drug and Dietary Supplement Revenue by Type (2021-2032)
  3. 10.2.1 China OTC Drug and Dietary Supplement Revenue by Type (2021-2026)
  4. 10.2.2 China OTC Drug and Dietary Supplement Revenue by Type (2027-2032)
  5. 10.3 China OTC Drug and Dietary Supplement Revenue Share by Type (2021-2032)
  6. 10.4 China OTC Drug and Dietary Supplement Revenue by Application (2021-2032)
  7. 10.4.1 China OTC Drug and Dietary Supplement Revenue by Application (2021-2026)
  8. 10.4.2 China OTC Drug and Dietary Supplement Revenue by Application (2027-2032)
  9. 10.5 China OTC Drug and Dietary Supplement Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia OTC Drug and Dietary Supplement Revenue (2021-2032)
  2. 11.2 Asia OTC Drug and Dietary Supplement Revenue by Type (2021-2032)
  3. 11.2.1 Asia OTC Drug and Dietary Supplement Revenue by Type (2021-2026)
  4. 11.2.2 Asia OTC Drug and Dietary Supplement Revenue by Type (2027-2032)
  5. 11.3 Asia OTC Drug and Dietary Supplement Revenue Share by Type (2021-2032)
  6. 11.4 Asia OTC Drug and Dietary Supplement Revenue by Application (2021-2032)
  7. 11.4.1 Asia OTC Drug and Dietary Supplement Revenue by Application (2021-2026)
  8. 11.4.2 Asia OTC Drug and Dietary Supplement Revenue by Application (2027-2032)
  9. 11.5 Asia OTC Drug and Dietary Supplement Revenue Share by Application (2021-2032)
  10. 11.6 Asia OTC Drug and Dietary Supplement Revenue by Country
  11. 11.6.1 Asia OTC Drug and Dietary Supplement Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia OTC Drug and Dietary Supplement Revenue by Country (2021-2026)
  13. 11.6.3 Asia OTC Drug and Dietary Supplement Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA OTC Drug and Dietary Supplement Revenue (2021-2032)
  2. 12.2 SAMEA OTC Drug and Dietary Supplement Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA OTC Drug and Dietary Supplement Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA OTC Drug and Dietary Supplement Revenue by Type (2027-2032)
  5. 12.3 SAMEA OTC Drug and Dietary Supplement Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA OTC Drug and Dietary Supplement Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA OTC Drug and Dietary Supplement Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA OTC Drug and Dietary Supplement Revenue by Application (2027-2032)
  9. 12.5 SAMEA OTC Drug and Dietary Supplement Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA OTC Drug and Dietary Supplement Revenue by Country
  11. 12.6.1 SAMEA OTC Drug and Dietary Supplement Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA OTC Drug and Dietary Supplement Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA OTC Drug and Dietary Supplement Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst